Description / anti-human VAP-1 polyclonal antibody
VAP-1 is a type II membrane cell adhesion protein belonging to the copper/topaquinone oxidase family. It is primarily expressed on the high endothelial venules of peripheral lymph nodes and on hepatic endothelia. VAP-1 can catalyze the oxidative deamination of low molecular weight amines, and plays an important role in the migration of lymphocytes to inflamed tissue. Inhibition of VAP-1 can protect against inflammation-related damage to certain injured tissues. Additionally, VAP-1 can function as a significant prognostic marker for certain cancers and cardiovascular diseases.
More Information
| Size | 100 µg |
|---|---|
| Source | Rabbit |
| Isotype | Rabbit IgG |
| Clone Nr. | Rabbit IgG |
| Species Reactivity | Human |
| Formulation | lyophilized |
| Reconstitution | Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml. |
| Stability and Storage | The lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C. |
| Preparation | Anti-Human VAP-1-specific antibody was purified by affinity chromatography employing an immobilized Human VAP-1 matrix. |
| Antigen | E.coli derived Recombinant Human VAP-1 (#100-141) |
| Application | WB, ELISA |
| Synonyms | AOC3; HPAO; SSAO; VAP1; VAP-1 |
| Uniprot ID | Q16853 |
| Protein RefSeq | NP_003725.1 |
| mRNA RefSeq | NM_003734.3 |